Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Basware in 2013: Transistion to Software as a Service
Burgelman, R; Schifrin, DCaso SGSB-SM219-EDirección estratégicaIn 2013 Basware, the Finland-based e-invoice operator and Enterprise Resource Planning (ERP) software vendor, was going through a large and critical transition: moving from selling and installing licensed software to selling Software as a Service (SaaS). Basware, which sold automated Purchase-to-Pay solutions for Business-to-Business to 2,000 Nordic and global clients, was responding to a sharp decline in those sales in the previous few years; mo...Desde 8,20 €
-
Axel Springer in 2016: From Transformation to Acceleration
Burgelman, R; Siegel, R; Kissick, RCaso SGSB-E610-EIniciativa emprendedoraAs of 2016, Mathias Döpfner, chief executive officer (CEO) of Axel Springer SE, had successfully transitioned the German publishing house through a major digital transformation in the world of journalism. Given the massive disruption that had occurred over the previous two decades with how people consumed news, this was no small feat. During this time, many newspapers, magazines, and journals failed to keep up with the rapidly changing industry...Desde 8,20 €
-
Invitrogen (A)
Burgelman, R; Siegel, R; Lee, RCaso SGSB-SM209A-EDirección estratégicaFounded in 1987, Invitrogen was one of the largest catalog life science companies in the industry. Its customers came from academic research, biotechnology and pharmaceutical companies and government laboratories. Scientists viewed Invitrogen as a one-stop shop for all major molecular biology, biochemistry and cell culture reagent products, with prices ranging from a hundred dollars to a few thousand dollars.Desde 8,20 €
-
Invitrogen/Life Technologies (B)
Burgelman, R; Siegel, R; Lee, RCaso SGSB-SM209B-EDirección estratégicaOn June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share’s closing price on Wednesday, June 11, 2008.Desde 5,74 €
-
Waste Management's Organic Growth Group
Burgelman, R; Siegel, R; Uribe, TCaso SGSB-SM210-EDirección estratégicaIt was 2005 and David Steiner, CEO of Waste Management (WM), had just received a report from an internal advisory panel created some months before to assess the future of the waste management industry and propose how the company’s strategy should be adapted. The core of this report was the recommendation to create a special unit within the company, chartered with the central purpose of identifying ways to extract value from waste through new and ...Desde 8,20 €
-
DKSH in 2011
Burgelman, R; , Ludescher, MCaso SGSB-SM204-EDirección estratégicaThe case describes the history and transformation of DKSH, a privately-held global trading company headquartered in Zurich, Switzerland, that has been doing business in the Far East for some 150 years. The case focuses on the efforts of CEO Joerg Wolle since 1999 to bring together several independent family-owned Swiss-based trading houses under one corporate roof and to transform successful but steady old-fashioned trading houses into a new type...Desde 8,20 €
-
SurveyMonkey in 2014
Burgelman, R; Siegel, R; Rosenthal, SCaso SGSB-E524-EIniciativa emprendedoraThe SurveyMonkey case portrays the evolution of the company from its founding in 1999 through to 2014. SurveyMonkey was launched by Ryan Finley, a young computer science graduate from the University of Wisconsin-Madison, to address the dearth of easy-to-use, affordable online survey tools on the market. In 2009, Finley sold the company to Spectrum Equity and Bain Capital Ventures, having recognized the need for a partner to help the company ach...Desde 8,20 €
-
Xiamoni's Globalization Strategy and Challenges
Burgelman, R; Gang, Zhang, Yanting, Fuo; Schifrin, DCaso SGSB-SM262-EDirección estratégicaXiaomi, the Chinese smartphone company founded in 2010, had quickly become an industry leader in the Chinese market. By 2016 it had started to expand internationally, and this case lays out the company’s globalization strategies and challenges moving forward. Hugo Barra, a top Android executive, had left Google a few years earlier to lead Xiaomi’s international growth. Xiaomi’s founder and CEO, Lei Jun, said the company’s ultimate goal was “makin...Desde 8,20 €
-
DKSH in 2011 and 2012 - Teaching note
Burgelman, R; , Ludescher, MCaso SGSB-SM204TN-EDirección estratégicaThe case discusses the post-IPO strategies, opportunities and challenges for Swiss global trading company DKSH, the leading market expansion (MES) provider with a focus on Asia. DKSH was well positioned to capitalize on three key MES industry trends: 1) Asia as the growth market per se, driven by the thriving middle classes of the emerging economies, 2) growing inner-Asian trade, and 3) the tendency of companies to outsource, stemming from the c...Desde 8,20 €
-
Invitrogen/Life Technologies (C): The "Best Owner" of the Asset
Burgelman, R; Siegel, R; Lee, RCaso SGSB-SM209C-EDirección estratégicaThis short case discusses the process of Life Technologies’ acquisition by Thermo Fisher in 2013 and 2014. The case is a complement to SM-209A and SM-209B, which highlight the various growth and acquisition strategies the company undertook over the previous 10 years.Desde 5,74 €